Health Security<Project Overview<Business-K-Health

Mission 1

We're establishing health security by securing vaccine and treatment sovereignty through timely R&D support.
This allows us to respond to government-wide and societal threats like infectious diseases and biochemical terrorism.

STOREx
Stockpile Technology to Omit Repeated Entityfor Vx
Development of Vaccine Technology for Ultra-Long-Term Stockpile
(Development of Ultra-Long-Term Vaccine Stockpiling Technologies)
View more
DeCAFx
DeCentralizing & Accelerating Facility for Vx

Development of a modular production system capable of ultra-rapid production of vaccines for pandemic response
(Development of a decentralized vaccine production system)
View more
PROCUREx
Pandemic Readiness for Outbreak Control & Urgent REscue with Tx

Development of therapeutics to suppress severe cases for responding to infectious disease pandemics

View more

Development of Vaccine Technology for Ultra-Long-Term Stockpile (Development of Ultra-Long-Term Vaccine Stockpiling Technologies)

(STOREx : Stockpile Technology to Omit Repeated Entityfor Vx)

Goal

Extending vaccine shelf life from 3 years to over 10 years to improve stockpiling methods and activate proactive vaccine stockpiling → Development of long-term vaccine preservation technology.

Development of vaccine technology enabling single production and long-term stockpiling for over 10 years.
Technology that enables proactive vaccine development and expansion of stockpiled vaccines.

Problem

Limited shelf life and uncertain timing of use make it difficult to establish effective stockpiling strategies.

Wasteful budget execution due to repeated production and disposal.
Shelf life acts as a barrier to proactive vaccine development and stockpiling strategies.

Innovation

Ultra-long-term shelf life extension through application of convergent technologies.

Combination of chemical degradation prevention and enhanced physical stability.

Utilization

Strengthening pandemic preparedness through expansion of vaccine stockpile types.

Improved budget efficiency through extended shelf life.
Activation of vaccine stockpiling strategies and expansion of response coverage.

Enhanced long-term storage stability based on MAPS technology.
Increased shelf life through inhibition of hydrolysis.

PM Introduction

Lee, Je Wook PM View Profile

Strengthening Health Security through Vaccine and Treatment Sovereignty

02-2288-6139
jwlee67@khidi.or.kr

list

Development of a modular production system capable of ultra-rapid production of vaccines for pandemic response (Development of a decentralized vaccine production system)

(DeCAFx : DeCentralizing & Accelerating Facility for Vx)

Goal

Integrated, Small-Scale, Mobile Vaccine Production Module Prototype Development → Rapid Vaccine Production Module Development

Develop a modular production system capable of rapidly producing 1 million doses within 100 days.
Develop a flexible modular production design that allows for on-site production in needed areas within 30 days.